07 Jan 2001

Collomack® (Collomack® Lösung) - Deutschland

Updated: 07 Jan 2001

Collomack®

Hyperkeratosen, Hühneraugen, Schwielen, Warzen.

Collomack® Description, Presentation and Dosage

Collomack® Description

Collomack® Drug Class Description

Kombinationen

Collomack® Drug Description

10 g enth.: Salicylsäure 2 g, Milchsäure 0,5 g, Polidocanol 0,2 g.

Collomack® Generic Name

Collomack® Lösung

Collomack® Presentation

Collomack® Presentation

Collomack®

Collomack® Manufacturer

Mack, Illert.

Related Learning Zones

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

Hyperammonaemia Knowledge Centre

Hyperammonaemia Knowledge Centre

The Hyperammonaemia Knowledge Centre has been developed to raise awareness of this rare yet potentially deadly condition. Using this resource, healthcare professionals are encouraged to recognise the signs and symptoms of hyperammonaemia and begin the correct treatment immediately.

Collomack® Dosage

Collomack® Adult Dosage

Dibutylphthalat, Ethylcellulose, Aceton.

Collomack® Precautions, Reactions and Contraindications

Collomack® Special Precautions

Collomack® Adverse Reactions

Collomack® Adverse Reactions

S 5

Related Drugs - Dermatology

Back to top